Opioid Prescriber Training: US FDA Still Debating Mandate; CMS Policies Having Impact Now

Even after convening a two-day meeting with speakers from across the health care sector to discuss how opioid prescriber education can be improved, FDA doesn’t seem any closer to determining how to mandate training – but there are some reasons to be optimistic about a 'culture' change nevertheless.